FAM
PRVL

Fred Alger Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Fred Alger Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,000
Closed -$47K – 605
2019
Q4 		$47K Buy
+3,000
New +$47K ﹤0.01% 432